Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis

OBJECTIVE: The androgen receptor-targeting drugs abiraterone acetate and enzalutamide have shown positive results as treatments for metastatic castration-resistant prostate cancer (mCRPC). Therefore, a meta-analysis was conducted to compare the efficacy and safety of abiraterone acetate and enzaluta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, ZhenHeng, Chen, ChuXin, Li, BoWen, Li, YongYue, Gu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429926/
https://www.ncbi.nlm.nih.gov/pubmed/34513709
http://dx.doi.org/10.3389/fonc.2021.732599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429926/
https://www.ncbi.nlm.nih.gov/pubmed/34513709
http://dx.doi.org/10.3389/fonc.2021.732599

Ejemplares similares